TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr | ₹338 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹445 Cr |
Mar2023 | ₹393 Cr |
Mar2022 | ₹369 Cr |
Mar2021 | ₹370 Cr |
Mar2020 | ₹338 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹445 Cr | 13.14 | |
Mar2023 | ₹393 Cr | 6.60 | |
Mar2022 | ₹369 Cr | -0.24 | |
Mar2021 | ₹370 Cr | 9.25 | |
Mar2020 | ₹338 Cr | - |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,458.9 Cr | 0.1% | 7.2% | 25.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -3% | 5.6% | 9.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | 1% | 2.7% | 70.3% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -2.7% | 0.4% | -0.4% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2% | 7.1% | 8.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -3.1% | -0.2% | -6.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 0.1% |
7.2% |
25.7% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses